Current Treatment of Pathological Myopia and Sclera-Targeted Therapies

Myopia is a refractive error that arises from the interaction of genetic and environmental factors. In recent years, there has been a significant increase in the prevalence of myopia. As the prevalence of myopia increases, so does the frequency of complications leading to vision loss associated with pathological myopia. Therefore, various methods and treatments are being explored to halt and prevent the progression of myopia in children. In myopia control, spending time outdoors, the use of low-dose atropine, and new generation lens technologies are being investigated. Spending more time outdoors appears to be the most reliable strategy. While some new lens designs seem to be quite effective in preventing progression, recent studies have shown that the expected success from atropine has not been achieved. Further research is needed on the long-term effects of combining different methods.